APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

OTC Drug and Dietary Supplement

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global OTC Drug and Dietary Supplement Market Outlook and Growth Opportunities 2026

Report ID 174021040431 December 2025195 pages

Choose your research edition.

Industry ResearchOTC Drug and Dietary Supplement Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Drug and Dietary Supplement Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal OTC Drug and Dietary Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Drug and Dietary Supplement Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Drug and Dietary Supplement Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global OTC Drug and Dietary Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for OTC Drug and Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Drug and Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Drug and Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the OTC Drug and Dietary Supplement market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the OTC Drug and Dietary Supplement market include Abbott, Pfizer, GSK, Bayer, Suntory, Reckitt Benckiser, Herbalife, Glanbia and Blackmores, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global OTC Drug and Dietary Supplement market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Drug and Dietary Supplement and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Drug and Dietary Supplement revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global OTC Drug and Dietary Supplement market.

OTC Drug and Dietary Supplement Segment by Company

Abbott

Pfizer

GSK

Bayer

Suntory

Reckitt Benckiser

Herbalife

Glanbia

Blackmores

Amway

OTC Drug and Dietary Supplement Segment by Type

Powders

Capsules

Tablets

Liquids

OTC Drug and Dietary Supplement Segment by Application

Convenience Stores

Supermarkets

Pharmacies

OTC Drug and Dietary Supplement Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global OTC Drug and Dietary Supplement status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the OTC Drug and Dietary Supplement key companies, revenue, market share, and recent developments.

3. To split the OTC Drug and Dietary Supplement breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions OTC Drug and Dietary Supplement market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify OTC Drug and Dietary Supplement significant trends, drivers, influence factors in global and regions.

6. To analyze OTC Drug and Dietary Supplement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Drug and Dietary Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Drug and Dietary Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Drug and Dietary Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Drug and Dietary Supplement industry.

Chapter 3: Detailed analysis of OTC Drug and Dietary Supplement company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of OTC Drug and Dietary Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of OTC Drug and Dietary Supplement in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. OTC Drug and Dietary Supplement Industry Trends Table 2. OTC Drug and Dietary Supplement Industry Drivers Table 3. OTC Drug and Dietary Supplement Industry Opportunities and Challenges Table 4. OTC Drug and Dietary Supplement Industry Restraints Table 5. Global OTC Drug and Dietary Supplement Revenue by Company (US$ Million) & (2021-2026) Table 6. Global OTC Drug and Dietary Supplement Revenue Share by Company (2021-2026) Table 7. Global OTC Drug and Dietary Supplement Company Ranking, (2024-2026) & (US$ Million) Table 8. Global OTC Drug and Dietary Supplement Key Company Manufacturing Base & Headquarters Table 9. Global OTC Drug and Dietary Supplement Company, Product Type & Application Table 10. Global OTC Drug and Dietary Supplement Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global OTC Drug and Dietary Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Powders Table 15. Significant Companies of Capsules Table 16. Significant Companies of Tablets Table 17. Significant Companies of Liquids Table 18. Global OTC Drug and Dietary Supplement Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global OTC Drug and Dietary Supplement Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global OTC Drug and Dietary Supplement Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global OTC Drug and Dietary Supplement Sales Value Share by Type (2021-2026) Table 22. Global OTC Drug and Dietary Supplement Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Convenience Stores Table 24. Significant Companies of Supermarkets Table 25. Significant Companies of Pharmacies Table 26. Global OTC Drug and Dietary Supplement Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global OTC Drug and Dietary Supplement Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global OTC Drug and Dietary Supplement Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global OTC Drug and Dietary Supplement Sales Value Share by Application (2021-2026) Table 30. Global OTC Drug and Dietary Supplement Sales Value Share by Application (2027-2032) Table 31. Global OTC Drug and Dietary Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global OTC Drug and Dietary Supplement Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global OTC Drug and Dietary Supplement Sales Value Share by Region (2021-2026) Table 34. Global OTC Drug and Dietary Supplement Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global OTC Drug and Dietary Supplement Sales Value Share by Region (2027-2032) Table 36. Global OTC Drug and Dietary Supplement Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global OTC Drug and Dietary Supplement Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global OTC Drug and Dietary Supplement Sales Value Market Share by Country (2021-2026) Table 39. Global OTC Drug and Dietary Supplement Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global OTC Drug and Dietary Supplement Sales Value Market Share by Country (2027-2032) Table 41. Abbott Company Information Table 42. Abbott Business Overview Table 43. Abbott OTC Drug and Dietary Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Abbott OTC Drug and Dietary Supplement Product Portfolio Table 45. Abbott Recent Development Table 46. Pfizer Company Information Table 47. Pfizer Business Overview Table 48. Pfizer OTC Drug and Dietary Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Pfizer OTC Drug and Dietary Supplement Product Portfolio Table 50. Pfizer Recent Development Table 51. GSK Company Information Table 52. GSK Business Overview Table 53. GSK OTC Drug and Dietary Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. GSK OTC Drug and Dietary Supplement Product Portfolio Table 55. GSK Recent Development Table 56. Bayer Company Information Table 57. Bayer Business Overview Table 58. Bayer OTC Drug and Dietary Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Bayer OTC Drug and Dietary Supplement Product Portfolio Table 60. Bayer Recent Development Table 61. Suntory Company Information Table 62. Suntory Business Overview Table 63. Suntory OTC Drug and Dietary Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Suntory OTC Drug and Dietary Supplement Product Portfolio Table 65. Suntory Recent Development Table 66. Reckitt Benckiser Company Information Table 67. Reckitt Benckiser Business Overview Table 68. Reckitt Benckiser OTC Drug and Dietary Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio Table 70. Reckitt Benckiser Recent Development Table 71. Herbalife Company Information Table 72. Herbalife Business Overview Table 73. Herbalife OTC Drug and Dietary Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Herbalife OTC Drug and Dietary Supplement Product Portfolio Table 75. Herbalife Recent Development Table 76. Glanbia Company Information Table 77. Glanbia Business Overview Table 78. Glanbia OTC Drug and Dietary Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Glanbia OTC Drug and Dietary Supplement Product Portfolio Table 80. Glanbia Recent Development Table 81. Blackmores Company Information Table 82. Blackmores Business Overview Table 83. Blackmores OTC Drug and Dietary Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Blackmores OTC Drug and Dietary Supplement Product Portfolio Table 85. Blackmores Recent Development Table 86. Amway Company Information Table 87. Amway Business Overview Table 88. Amway OTC Drug and Dietary Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Amway OTC Drug and Dietary Supplement Product Portfolio Table 90. Amway Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. OTC Drug and Dietary Supplement Product Image Figure 2. Global OTC Drug and Dietary Supplement Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Drug and Dietary Supplement Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Powders Image Figure 8. Capsules Image Figure 9. Tablets Image Figure 10. Liquids Image Figure 11. Global OTC Drug and Dietary Supplement Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global OTC Drug and Dietary Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global OTC Drug and Dietary Supplement Sales Value Share by Type (2021-2032) Figure 14. Convenience Stores Image Figure 15. Supermarkets Image Figure 16. Pharmacies Image Figure 17. Global OTC Drug and Dietary Supplement Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global OTC Drug and Dietary Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global OTC Drug and Dietary Supplement Sales Value Share by Application (2021-2032) Figure 20. Global OTC Drug and Dietary Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global OTC Drug and Dietary Supplement Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America OTC Drug and Dietary Supplement Sales Value (2021-2032) & (US$ Million) Figure 23. North America OTC Drug and Dietary Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe OTC Drug and Dietary Supplement Sales Value (2021-2032) & (US$ Million) Figure 25. Europe OTC Drug and Dietary Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific OTC Drug and Dietary Supplement Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific OTC Drug and Dietary Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America OTC Drug and Dietary Supplement Sales Value (2021-2032) & (US$ Million) Figure 29. South America OTC Drug and Dietary Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa OTC Drug and Dietary Supplement Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa OTC Drug and Dietary Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Powders
  • Capsules
  • Tablets
  • Liquids
Applications
  • Convenience Stores
  • Supermarkets
  • Pharmacies
Companies covered
  • Abbott
  • Pfizer
  • GSK
  • Bayer
  • Suntory
  • Reckitt Benckiser
  • Herbalife
  • Glanbia
  • Blackmores
  • Amway

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Drug and Dietary Supplement Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Drug and Dietary Supplement Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 OTC Drug and Dietary Supplement Market Dynamics
  1. 2.1 OTC Drug and Dietary Supplement Industry Trends
  2. 2.2 OTC Drug and Dietary Supplement Industry Drivers
  3. 2.3 OTC Drug and Dietary Supplement Industry Opportunities and Challenges
  4. 2.4 OTC Drug and Dietary Supplement Industry Restraints
3 OTC Drug and Dietary Supplement Market by Company
  1. 3.1 Global OTC Drug and Dietary Supplement Company Revenue Ranking in 2025
  2. 3.2 Global OTC Drug and Dietary Supplement Revenue by Company (2021-2026)
  3. 3.3 Global OTC Drug and Dietary Supplement Company Ranking (2024-2026)
  4. 3.4 Global OTC Drug and Dietary Supplement Company Manufacturing Base and Headquarters
  5. 3.5 Global OTC Drug and Dietary Supplement Company Product Type and Application
  6. 3.6 Global OTC Drug and Dietary Supplement Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global OTC Drug and Dietary Supplement Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 OTC Drug and Dietary Supplement Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 OTC Drug and Dietary Supplement Market by Type
  1. 4.1 OTC Drug and Dietary Supplement Type Introduction
  2. 4.1.1 Powders
  3. 4.1.2 Capsules
  4. 4.1.3 Tablets
  5. 4.1.4 Liquids
  6. 4.2 Global OTC Drug and Dietary Supplement Sales Value by Type
  7. 4.2.1 Global OTC Drug and Dietary Supplement Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global OTC Drug and Dietary Supplement Sales Value by Type (2021-2032)
  9. 4.2.3 Global OTC Drug and Dietary Supplement Sales Value Share by Type (2021-2032)
5 OTC Drug and Dietary Supplement Market by Application
  1. 5.1 OTC Drug and Dietary Supplement Application Introduction
  2. 5.1.1 Convenience Stores
  3. 5.1.2 Supermarkets
  4. 5.1.3 Pharmacies
  5. 5.2 Global OTC Drug and Dietary Supplement Sales Value by Application
  6. 5.2.1 Global OTC Drug and Dietary Supplement Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global OTC Drug and Dietary Supplement Sales Value by Application (2021-2032)
  8. 5.2.3 Global OTC Drug and Dietary Supplement Sales Value Share by Application (2021-2032)
6 OTC Drug and Dietary Supplement Regional Value Analysis
  1. 6.1 Global OTC Drug and Dietary Supplement Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Drug and Dietary Supplement Sales Value by Region (2021-2032)
  3. 6.2.1 Global OTC Drug and Dietary Supplement Sales Value by Region: 2021-2026
  4. 6.2.2 Global OTC Drug and Dietary Supplement Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Drug and Dietary Supplement Sales Value (2021-2032)
  7. 6.3.2 North America OTC Drug and Dietary Supplement Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe OTC Drug and Dietary Supplement Sales Value (2021-2032)
  10. 6.4.2 Europe OTC Drug and Dietary Supplement Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific OTC Drug and Dietary Supplement Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific OTC Drug and Dietary Supplement Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America OTC Drug and Dietary Supplement Sales Value (2021-2032)
  16. 6.6.2 South America OTC Drug and Dietary Supplement Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa OTC Drug and Dietary Supplement Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa OTC Drug and Dietary Supplement Sales Value Share by Country, 2025 VS 2032
7 OTC Drug and Dietary Supplement Country-level Value Analysis
  1. 7.1 Global OTC Drug and Dietary Supplement Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global OTC Drug and Dietary Supplement Sales Value by Country (2021-2032)
  3. 7.2.1 Global OTC Drug and Dietary Supplement Sales Value by Country (2021-2026)
  4. 7.2.2 Global OTC Drug and Dietary Supplement Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt OTC Drug and Dietary Supplement Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt OTC Drug and Dietary Supplement Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt OTC Drug and Dietary Supplement Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott OTC Drug and Dietary Supplement Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer OTC Drug and Dietary Supplement Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK OTC Drug and Dietary Supplement Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer OTC Drug and Dietary Supplement Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Suntory
  26. 8.5.1 Suntory Company Information
  27. 8.5.2 Suntory Business Overview
  28. 8.5.3 Suntory OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Suntory OTC Drug and Dietary Supplement Product Portfolio
  30. 8.5.5 Suntory Recent Developments
  31. 8.6 Reckitt Benckiser
  32. 8.6.1 Reckitt Benckiser Company Information
  33. 8.6.2 Reckitt Benckiser Business Overview
  34. 8.6.3 Reckitt Benckiser OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio
  36. 8.6.5 Reckitt Benckiser Recent Developments
  37. 8.7 Herbalife
  38. 8.7.1 Herbalife Company Information
  39. 8.7.2 Herbalife Business Overview
  40. 8.7.3 Herbalife OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Herbalife OTC Drug and Dietary Supplement Product Portfolio
  42. 8.7.5 Herbalife Recent Developments
  43. 8.8 Glanbia
  44. 8.8.1 Glanbia Company Information
  45. 8.8.2 Glanbia Business Overview
  46. 8.8.3 Glanbia OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Glanbia OTC Drug and Dietary Supplement Product Portfolio
  48. 8.8.5 Glanbia Recent Developments
  49. 8.9 Blackmores
  50. 8.9.1 Blackmores Company Information
  51. 8.9.2 Blackmores Business Overview
  52. 8.9.3 Blackmores OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Blackmores OTC Drug and Dietary Supplement Product Portfolio
  54. 8.9.5 Blackmores Recent Developments
  55. 8.10 Amway
  56. 8.10.1 Amway Company Information
  57. 8.10.2 Amway Business Overview
  58. 8.10.3 Amway OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Amway OTC Drug and Dietary Supplement Product Portfolio
  60. 8.10.5 Amway Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst